Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
38.6K
-
Shares change
-
+7.24K
-
Total reported value, excl. options
-
$738K
-
Value change
-
+$138K
-
Number of buys
-
2
-
Price
-
$19.10
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q4 2023
2 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.6K shares
of 106M outstanding shares and own 0.04% of the company stock.
Largest 10 shareholders include BlackRock Inc. (10M shares), FMR LLC (4.73M shares), VANGUARD GROUP INC (4.68M shares), STATE STREET CORP (4.24M shares), Octagon Capital Advisors LP (1.87M shares), AMERIPRISE FINANCIAL INC (1.63M shares), Invus Financial Advisors, LLC (1.61M shares), Boxer Capital, LLC (1.6M shares), DIMENSIONAL FUND ADVISORS LP (1.59M shares), and ALLIANCEBERNSTEIN L.P. (1.19M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.